Oslo, 23 May 2025: Reference is made to the stock exchange announcement by NEXT
Biometrics Group ASA ("NEXT" or the "Company") on 9 May 2025 regarding the
resolution by the Annual General to grant share options to board members.

The below primary insiders of the Company have now entered into share option
allocation letter agreements setting out the terms and conditions for the
following number of share options granted to them:

- Hans Henrik Klouman (Chairman) has been granted 1,000,000 share options in the
Company, following which he holds in total 1,000,000 share options.

- Tove Giske (Director) has been granted 200,000 share options in the Company,
following which she holds in total 200,000 share options.

- Roy Tselentis (Director) has been granted 200,000 share options in the
Company, following which he holds in total 200,000 share options.

Moreover, the exercise period for Siri Gomnæs Børsum's (Director) 200,000 share
options in the Company has been extended from 1 June 2025 to 30 July 2027. Siri
Gomnæs Børsum holds in total 200,000 share options.

With regard to the 2025 option program for board members, in total 50% of the
options will vest on 9 May 2026 and 50% of the options will vest on 9 May 2027.
For board members, the date of expiry for all vested options is the date falling
60 months after the date of grant. Any options that are not exercised at, or
prior to, that date will lapse. The vesting period for the options is
conditional on the person being a member of the board of directors at the date
of vesting, meaning that the options that have not vested will lapse without
compensation to the holder if the board member ceases to be a member of the
board. Options that have vested shall not lapse without compensation before the
expiry period of the options. Vested options must be exercised within six months
from the date of the end of the board member's term.

The exercise price of the share options shall be equal to the average volume
weighted market price of the Company's shares over the last five trading days
prior to the date of grant, being NOK 5.16 for the board members that have now
been granted options.

After the above-mentioned allotment, if all conditions are met, the total number
of issued share options in the Company is 11,410,079.

This information is subject to the disclosure requirements pursuant to Article
19 of the EU Market Abuse Regulation and section 5-12 of the Norwegian
Securities Trading Act.

NEXT Investor contact:
Ulf Ritsvall (CEO), ulf.ritsvall@nextbiometrics.com
Eirik Underthun (CFO), eirik.underthun@nextbiometrics.com

About NEXT Biometrics
NEXT provides advanced fingerprint sensor technology that delivers uncompromised
security and accuracy for the best possible user experience in the payment and
fintech, government ID, access control and office and notebook markets. The
company's patented NEXT Active Thermal ® principle allows the development of
large, high-quality fingerprint sensors with superior security level. NEXT
Biometrics Group ASA is headquartered in Oslo, with sales, support, and
development operations in Seattle, Taipei, Tokyo, New Delhi and Shanghai.